191 related articles for article (PubMed ID: 32611433)
1. Poorer prognosis of ovarian squamous cell carcinoma than serous carcinoma: a propensity score matching analysis based on the SEER database.
Zhang C; Ma T
J Ovarian Res; 2020 Jul; 13(1):75. PubMed ID: 32611433
[TBL] [Abstract][Full Text] [Related]
2. Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis.
Pan X; Yang W; Wen Z; Li F; Tong L; Tang W
J Gynecol Oncol; 2020 Nov; 31(6):e80. PubMed ID: 33078590
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based Analysis.
Han Y; Wang J; Wang Z; Xu B
Cancer Control; 2021; 28():10732748211044355. PubMed ID: 34654324
[TBL] [Abstract][Full Text] [Related]
4. Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis.
Wu SG; Zhang WW; Sun JY; Li FY; He ZY; Zhou J
Int J Surg; 2017 Dec; 48():122-127. PubMed ID: 29032160
[TBL] [Abstract][Full Text] [Related]
5. Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Jun; 15(3):e463-e468. PubMed ID: 27876505
[TBL] [Abstract][Full Text] [Related]
6. Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary.
Wu H; Jiang S; Zhong P; Li W; Zhang S
J Ovarian Res; 2021 Oct; 14(1):137. PubMed ID: 34674727
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery.
Li S; Zhu Z
J Ovarian Res; 2020 Aug; 13(1):91. PubMed ID: 32772926
[TBL] [Abstract][Full Text] [Related]
8. Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database.
Li X; Yang Q; Chen M; Yang C; Gu J; Dong Q; Yang G
J Ovarian Res; 2021 Feb; 14(1):40. PubMed ID: 33640000
[TBL] [Abstract][Full Text] [Related]
9. Comparison of outcomes between rectal squamous cell carcinoma and adenocarcinoma.
Chiu MS; Verma V; Bennion NR; Bhirud AR; Li J; Charlton ME; Are C; Lin C
Cancer Med; 2016 Dec; 5(12):3394-3402. PubMed ID: 27781400
[TBL] [Abstract][Full Text] [Related]
10. Primary squamous cell carcinoma of the ovary. Review of the literature.
Koufopoulos N; Nasi D; Goudeli C; Antoniadou F; Kokkali S; Pigadioti E; Provatas I; Maggo E; Ardavanis A; Terzakis E; Arkoumani E; J Agnantis N; Apostolikas N; Khaldi L
J BUON; 2019; 24(5):1776-1784. PubMed ID: 31786837
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcomes of squamous ovarian carcinoma; a population-based study.
Nasioudis D; Sisti G; Kanninen TT; Holcomb K; Di Tommaso M; Fambrini M; Witkin SS
Gynecol Oncol; 2016 Apr; 141(1):128-33. PubMed ID: 26867989
[TBL] [Abstract][Full Text] [Related]
12. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Clinical Characteristic and Prognosis between Ovarian Clear Cell Carcinoma and Serous Carcinoma: A 10-Year Cohort Study of Chinese Patients.
Ye S; Yang J; You Y; Cao D; Huang H; Wu M; Chen J; Lang J; Shen K
PLoS One; 2015; 10(7):e0133498. PubMed ID: 26186453
[TBL] [Abstract][Full Text] [Related]
14. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
[TBL] [Abstract][Full Text] [Related]
16. Grading ovarian serous carcinoma using a two-tier system.
Malpica A; Deavers MT; Lu K; Bodurka DC; Atkinson EN; Gershenson DM; Silva EG
Am J Surg Pathol; 2004 Apr; 28(4):496-504. PubMed ID: 15087669
[TBL] [Abstract][Full Text] [Related]
17. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis.
Rauh-Hain JA; Diver EJ; Clemmer JT; Bradford LS; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
Gynecol Oncol; 2013 Oct; 131(1):46-51. PubMed ID: 23906658
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Transitional Cell Carcinoma-Like Morphology of High-Grade Serous Ovarian Carcinoma: A Comparative Study.
Nasioudis D; Sisti G; Kanninen TT; Fambrini M; Di Tommaso M
Int J Gynecol Cancer; 2016 Nov; 26(9):1624-1629. PubMed ID: 27575630
[TBL] [Abstract][Full Text] [Related]
19. Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: A retrospective observational cohort study.
Hu D; Ma D; Zhang ZJ; Zhang Y; Huang K; Li X
Front Endocrinol (Lausanne); 2023; 14():1103429. PubMed ID: 36742399
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of bulky pTIIB cervical cancer treated by radical hysterectomy comparing adenocarcinoma with squamous cell carcinoma using propensity score matching.
Okadome M; Nagayama R; Shimokawa M; Sonoda K; Shimamoto K; Saito T
Int J Gynaecol Obstet; 2021 Apr; 153(1):56-63. PubMed ID: 33119174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
